These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15081792)

  • 21. Gender differences in hyperthermia and regional 5-HT and 5-HIAA depletion in the brain following MDMA administration in rats.
    Wallinga AE; Grahlmann C; Granneman RA; Koolhaas JM; Buwalda B
    Brain Res; 2011 Jun; 1398():13-20. PubMed ID: 21620380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanisms underlying amiloride enhancement of 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
    Goñi-Allo B; Puerta E; Hervias I; Di Palma R; Ramos M; Lasheras B; Aguirre N
    Eur J Pharmacol; 2007 May; 562(3):198-207. PubMed ID: 17320075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
    Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
    Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
    Thompson MR; Li KM; Clemens KJ; Gurtman CG; Hunt GE; Cornish JL; McGregor IS
    Neuropsychopharmacology; 2004 Apr; 29(4):694-704. PubMed ID: 14627999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat.
    Cassel JC; Riegert C; Rutz S; Koenig J; Rothmaier K; Cosquer B; Lazarus C; Birthelmer A; Jeltsch H; Jones BC; Jackisch R
    Neuropsychopharmacology; 2005 Oct; 30(10):1870-82. PubMed ID: 15785779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB; Compton DR; Martin BR
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
    McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
    Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ; Vu HL; Safain MG; Oliver AJ; Meyer JS
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the endocannabinoid system in MDMA intracerebral self-administration in rats.
    Braida D; Sala M
    Br J Pharmacol; 2002 Aug; 136(8):1089-92. PubMed ID: 12163340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological effects of cannabinoids on the reference and working memory functions in mice.
    Avdesh A; Hoe Y; Martins RN; Martin-Iverson MT
    Psychopharmacology (Berl); 2013 Jan; 225(2):483-94. PubMed ID: 22903389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze.
    Takahashi RN; Pamplona FA; Fernandes MS
    Neurosci Lett; 2005 Jun; 380(3):270-5. PubMed ID: 15862900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for an interaction between CB1 cannabinoid and oxytocin receptors in food and water intake.
    Verty AN; McFarlane JR; McGregor IS; Mallet PE
    Neuropharmacology; 2004 Sep; 47(4):593-603. PubMed ID: 15380376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors.
    Govaerts SJ; Hermans E; Lambert DM
    Eur J Pharm Sci; 2004 Nov; 23(3):233-43. PubMed ID: 15489124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm.
    De Vry J; Jentzsch KR
    Behav Pharmacol; 2003 Sep; 14(5-6):471-6. PubMed ID: 14501260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats.
    Morley KC; Cornish JL; Li KM; McGregor IS
    Pharmacol Biochem Behav; 2004 Oct; 79(2):331-42. PubMed ID: 15501310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).
    Nawata Y; Hiranita T; Yamamoto T
    Neuropsychopharmacology; 2010 Jan; 35(2):515-20. PubMed ID: 19829291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MDMA attenuates THC withdrawal syndrome in mice.
    Touriño C; Maldonado R; Valverde O
    Psychopharmacology (Berl); 2007 Jul; 193(1):75-84. PubMed ID: 17387458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.
    Gurtman CG; Morley KC; Li KM; Hunt GE; McGregor IS
    Eur J Pharmacol; 2002 Jun; 446(1-3):89-96. PubMed ID: 12098589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.